Clinical trials: Chronic Diabetic Macular Edema
Diabetic Macular Edema (DME)
Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies
This observational study aims to assess the safety and effect of Iluvien® in DME patients considered insufficiently responsive to available therapies in a real life setting in Germany.
- Trial name
- ILUMINATE (NCT02080091)
- Where
- Germany
- Volunteers
- 25 people
- Sponsor
- Alimera Sciences
Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies
Iluvien Registry Safety Study
The study will include any patient treated with Iluvien at designated sites in European countries where marketing authorization has been granted in order to obtain broader safety and usage information.
- Trial name
- IRISS (NCT01998412)
- Where
- United States
- Volunteers
- 559 people
- Sponsor
- Alimera Sciences
Chronic Diabetic Macular Edema
A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy
A phase 4 trial evaluating the effect and safety of ILUVIEN in chronic DME patients insufficiently responsive to available therapies.
- Trial name
- NCT02472366
- Testing
- ILUVIEN
- Volunteers
- 16 people
- Sponsor
- Alimera Sciences